Dr. Sartor Discusses Custirsen As Treatment For Prostate Cancer

2015 1:04
Synopsis
Oliver Sartor, MD, board professor, cancer research, Tulane University, discusses a phase III trial of custirsen (OGX-011) and its ...

You Might Also Like

Dr. Sartor on Progress for the Treatment of Prostate Cancer 1:25
Dr. Sartor On Progress For The Treatment Of Prostate Cancer
2014
Dr. Oliver Sartor talks about a new treatment for advanced prostate cancer 1:26
Dr. Oliver Sartor Talks About A New Treatment For Advanced P...
2022
Dr. Sartor Discusses Sequencing Therapies in Prostate Cancer 2:09
Dr. Sartor Discusses Sequencing Therapies In Prostate Cancer
2016
Dr. Sartor on Promising Treatment Approaches in Prostate Cancer 1:56
Dr. Sartor On Promising Treatment Approaches In Prostate Can...
2021
Dr. Sartor Discusses Prostate Cancer Drug Combinations 0:42
Dr. Sartor Discusses Prostate Cancer Drug Combinations
2012
Dr. Sartor on the Next Steps with Sipuleucel-T for Prostate Cancer 0:51
Dr. Sartor On The Next Steps With Sipuleucel-t For Prostate ...
2018
Dr. Petrylak Discusses Custirsen as a Potential Treatment for Prostate Cancer 0:34
Dr. Petrylak Discusses Custirsen As A Potential Treatment Fo...
2015
Dr. Sartor Discusses PSA Testing for Prostate Cancer 1:52
Dr. Sartor Discusses Psa Testing For Prostate Cancer
2015
Dr. Sartor on the Science of Sipuleucel-T for Prostate Cancer 1:01
Dr. Sartor On The Science Of Sipuleucel-t For Prostate Cance...
2018
Dr. Sartor on Recent Progress on the Molecular Front for the Treatment of Prostate Cancer 1:36
Dr. Sartor On Recent Progress On The Molecular Front For The...
2014
Dr. Oliver Sartor Discusses Radium-223 in Early Prostate Cancer 1:04
Dr. Oliver Sartor Discusses Radium-223 In Early Prostate Can...
2013
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.